FDA
Articles tagged with “FDA”
NRx Pharma Gets FDA Expanded Access for Ketamine Protocol
NRx Pharmaceuticals received an FDA Expanded Access grant for its ketamine-bridging treatment program. Here's what it means for patients and oral ketamine access.
FDA Signals Support for Preservative-Free Ketamine
The FDA has issued a positive response on preservative-free ketamine formulations. Here's what this regulatory shift means for oral ketamine tablet patients.
NRx's Preservative-Free Ketamine Moves Closer to FDA OK
NRx Pharmaceuticals reports progress on its FDA application for preservative-free ketamine. Here's what this could mean for tablets, dosing, and patient access.
Trump EO on Psychedelics: What It Means for Ketamine
President Trump signed an executive order accelerating psychedelic research and access. Here's what oral ketamine tablet patients need to know about what changes.
FDA Considerations for Ketamine Tablet
Understand the FDA's regulatory position on ketamine tablet: off-label use, compounding regulations, DEA scheduling, and potential pathways to future approval.
Contact Ketamine Tablet
Send corrections, provider questions, or advertising inquiries.